Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)

Detailed Status

Recruiting1
Terminated1
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting125%
terminated125%
not_yet_recruiting125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Registry of Subjects at Risk of Pancreatic Cancer

NCT04095195
not_yet_recruitingnot_applicable

Clinical Application of Annual Liver Multiscan and MRCP+ in Primary Sclerosing Cholangitis

NCT05462093
completed

Repeatability and Reproducibility of Quantitative MRCP

NCT03809559
terminatedphase_3

Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction

NCT01424657

Clinical Trials (4)

Showing 4 of 4 trials
NCT04095195

Registry of Subjects at Risk of Pancreatic Cancer

Recruiting
NCT05462093Not Applicable

Clinical Application of Annual Liver Multiscan and MRCP+ in Primary Sclerosing Cholangitis

Not Yet Recruiting
NCT03809559

Repeatability and Reproducibility of Quantitative MRCP

Completed
NCT01424657Phase 3

Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary Obstruction

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4